Eversept Partners’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
Other funds holding NXTC
Eversept Partners's NXTC Position: Q3 2026 in Review
Eversept Partners opened a new position in NextCure (NXTC) in Q3 2026: 185,455 shares worth $929K. The stake represents 0.05% of the portfolio and ranks #97 among its holdings.
29 funds tracked by Wall St. Rank hold NXTC as of Q3 2026.
- Eversept Partners held 185,455 shares of NextCure worth $929K as of Q3 2026.
- NextCure was a new Eversept Partners position in Q3 2026.
- NextCure made up 0.05% of Eversept Partners's portfolio in Q3 2026, its #97 holding.
- 29 funds tracked by Wall St. Rank held NextCure as of Q3 2026.
Based on Eversept Partners's 13F filing for Q3 2026, filed 16 Nov 2026.